BLCO - Trade Savi - 360-degree view on crypto market

BLCO

BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances

Bank of America rates Bausch + Lomb Corp as 'underperform' with an $18 price target due to reduced private equity buyout prospects and uncertainties around its spin-off from Bausch Health.

investing.com • 13/12/2024 - 15:35 PM

BHC BLCO

Bausch + Lomb stock extends gains as Jefferies describes it as an 'undervalued asset'

Jefferies values Bausch + Lomb at $25 per share, citing high potential returns and a possible sale beneficial for stakeholders amid ongoing acquisition speculation.

investing.com • 12/12/2024 - 16:25 PM

BLCO

Bausch + Lomb down after report that Blackstone could back away from takeover bid

Bausch + Lomb shares fell over 12% amid reports Blackstone may withdraw from a joint bid, raising concerns over the eyecare company's acquisition amid high price expectations.

investing.com • 11/12/2024 - 15:58 PM

BLCO

Bausch + Lomb posts top-line beat, raises full-year outlook

Bausch + Lomb's Q3 revenue surpassed expectations at $1.196 billion, prompting an increase in full-year guidance, driven by strong growth across all product segments.

investing.com • 30/10/2024 - 11:09 AM

Greed and Fear Index

Note: The data is for reference only.

Extreme Greed

BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances

Bausch + Lomb stock extends gains as Jefferies describes it as an 'undervalued asset'

Bausch + Lomb down after report that Blackstone could back away from takeover bid

Bausch + Lomb posts top-line beat, raises full-year outlook

Greed and Fear Index

Currency